These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8001407)

  • 21. A human/mouse chimeric monoclonal antibody against CA125 for radioimmunoimaging of ovarian cancer.
    Kobayashi H; Sakahara H; Saga T; Hosono M; Shirato M; Kanda H; Ishibashi K; Watanabe T; Endo K; Ishiwata I
    Cancer Immunol Immunother; 1993 Aug; 37(3):143-9. PubMed ID: 7687520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioimmunodetection of primary and metastatic ovarian cancer using radiolabeled antibodies to carcinoembryonic antigen.
    van Nagell JR; Kim E; Casper S; Primus FJ; Bennett S; DeLand FH; Goldenberg DM
    Cancer Res; 1980 Mar; 40(3):502-6. PubMed ID: 7471071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA102: experience of 20 cases].
    Murakami K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Wada K; Sakuma S; Takagi H
    Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):119-27. PubMed ID: 8464409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A clinical evaluation of MAb BW 835/6 in breast and ovarian cancer].
    Trampert L; Villena C; Benz P; Keweloh HC; Schmidt W; Oberhausen E
    Nuklearmedizin; 1992 Dec; 31(6):249-53. PubMed ID: 1491965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
    Zhu W; Michael CW
    Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of breast carcinoma with radiolabeled monoclonal antibodies (MoAbs) to carcinoembryonic antigen (CEA) and human milk fat globulin (HMFG).
    Rosner D; Nabi H; Wild L; Ortman-Nabi J; Hreshchyshyn MM
    Cancer Invest; 1995; 13(6):573-82. PubMed ID: 7583706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiolabeled chimeric anti-CEA monoclonal antibody compared with the original mouse monoclonal antibody for surgically treated colorectal carcinoma.
    Buchegger F; Mach JP; Pèlegrin A; Gillet M; Vogel CA; Buclin T; Ryser JE; Delaloye B; Delaloye AB
    J Nucl Med; 1995 Mar; 36(3):420-9. PubMed ID: 7884504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospects of radioimmunotherapy in epithelial ovarian cancer: results with iodine-131-labeled murine and humanized MN-14 anti-carcinoembryonic antigen monoclonal antibodies.
    Juweid M; Swayne LC; Sharkey RM; Dunn R; Rubin AD; Herskovic T; Goldenberg DM
    Gynecol Oncol; 1997 Dec; 67(3):259-71. PubMed ID: 9441773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical immunoscintigraphy of ovarian carcinoma using iodine-131-labeled 145-9 monoclonal antibody.
    Chung JK; Kang SB; Lee HP; Lee MC; Koh CS; Sakahara H; Endo K
    J Nucl Med; 1993 Oct; 34(10):1651-5. PubMed ID: 8410277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carcinoembryonic antigen radioimmunodetection in the evaluation of colorectal cancer and in the detection of occult neoplasms.
    Goldenberg DM; Kim EE; Bennett SJ; Nelson MO; Deland FH
    Gastroenterology; 1983 Mar; 84(3):524-32. PubMed ID: 6295871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity.
    Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J
    Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The clinical value of tissue polypeptide antigen in ovarian carcinoma].
    Wu L; Sun J; Wang X
    Zhonghua Fu Chan Ke Za Zhi; 1998 Feb; 33(2):92-4. PubMed ID: 10682428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regression of advanced refractory ovarian cancer treated with iodine-131-labeled anti-CEA monoclonal antibody.
    Juweid M; Sharkey RM; Alavi A; Swayne LC; Herskovic T; Hanley D; Rubin AD; Pereira M; Goldenberg DM
    J Nucl Med; 1997 Feb; 38(2):257-60. PubMed ID: 9025751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IMMULITE OM-MA assay: a useful diagnostic tool in patients with benign and malignant ovarian tumors.
    Gebauer G; Rieger M; Jäger W; Lang N
    Anticancer Res; 1999; 19(4A):2535-6. PubMed ID: 10470190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments.
    Goldenberg DM; Wlodkowski TJ; Sharkey RM; Silberstein EB; Serafini AN; Garty II; Van Heertum RL; Higginbotham-Ford EA; Kotler JA; Balasubramanian N
    J Nucl Med; 1993 Jan; 34(1):61-70. PubMed ID: 8418273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical application of radioimmunoimaging in the detection of tumors--current status in China.
    Zhou Q
    Chin Med Sci J; 1992 Jun; 7(2):116-21. PubMed ID: 1280474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative evaluation of diagnostic significance of carbohydrate antigen CA125 and cancer-embryonal antigen in ovarian cancer].
    Lapchenkov VI; Dudarev AL; Vinokurov VL; Iurkova LE; Barbanel EIu
    Vestn Rentgenol Radiol; 1993; (5):30-1. PubMed ID: 7801580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
    Casalini P; Luison E; Ménard S; Colnaghi MI; Paganelli G; Canevari S
    J Nucl Med; 1997 Sep; 38(9):1378-81. PubMed ID: 9293791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioimmunoscintigraphy with technetium-99m-labelled monoclonal antibody, SM3, in gynaecological cancer.
    Granowska M; Britton KE; Mather SJ; Lowe DG; Ellison D; Bomanji J; Burchell J; Taylor-Papadimitriou J; Hudson CR; Shepherd JH
    Eur J Nucl Med; 1993 Jun; 20(6):483-9. PubMed ID: 8339731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.